KALV stock

Kalvista Pharmaceuticals Inc (KALV) financials · $1.44B cap

Lician Pro · $19.99/mo or $149/yrCompare AAPL vs MSFT

Kalvista Pharmaceuticals Inc (KALV) $1.44B cap.

Cached annual income statement
LineFY2025FY2024
RevenueN/A$50.0M
Operating Income-$188.0MN/A
Net Income-$183.4M-$126.6M
EPS (Diluted)-$3.69-$3.44
Cached annual balance sheet
LineFY2025FY2024
Total Assets$250.8M$235.4M
Current Assets$241.7M$225.7M
Cash & Equivalents$131.6M$31.8M
PP&E$1.99M$2.23M
Total Liabilities$155.4M$28.8M
Current Liabilities$45.2M$22.8M
Shareholders' Equity$95.4M$206.6M
Retained Earnings-$653.2M-$469.7M
Cached annual cash flow
LineFY2025FY2024
Operating Cash Flow-$152.9M-$89.2M
CapEx$434.0KN/A
Investing Cash Flow$91.0M-$84.7M
Financing Cash Flow$159.7M$150.7M
Net Change in Cash$100.5MN/A
Free Cash Flow-$153.3MN/A
These statements as JSON? API free 100/day

FAQ

What is KALV P/E and revenue?

Kalvista Pharmaceuticals Inc (KALV) $1.44B cap.

What is KALV revenue?

KALV income-statement cache has no revenue figure yet.

Is KALV profitable?

Kalvista Pharmaceuticals Inc last cached net income is -$183.4M (FY2025).

What are KALV total assets?

Kalvista Pharmaceuticals Inc last cached total assets are $250.8M (FY2025).

What is KALV free cash flow?

Kalvista Pharmaceuticals Inc last cached free cash flow is -$153.3M (FY2025).

Not investment advice. Cached statements, not a live tape.